Common Contracts

CONFIDENTIAL August 4, 2020

Placement Agent Agreement • August 6th, 2020 • Sintx Technologies, Inc. • Surgical & medical instruments & apparatus • New York

• Contract Type
  Placement Agent Agreement
• Filed
  August 6th, 2020
• Company
  Sintx Technologies, Inc.
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  New York

CONFIDENTIAL July 16, 2020 Dr. B. Sonny Bal, M.D., Ph.D. Chairman, Chief Executive Officer & President SINTX Technologies, Inc.

Placement Agent Agreement • July 20th, 2020 • Sintx Technologies, Inc. • Surgical & medical instruments & apparatus • New York

• Contract Type
  Placement Agent Agreement
• Filed
  July 20th, 2020
• Company
  Sintx Technologies, Inc.
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  New York

CONFIDENTIAL June 26, 2020 Dr. B. Sonny Bal, M.D., Ph.D. Chairman, Chief Executive Officer & President SINTX Technologies, Inc.

Placement Agent Agreement • June 30th, 2020 • Sintx Technologies, Inc. • Surgical & medical instruments & apparatus • New York

• Contract Type
  Placement Agent Agreement
• Filed
  June 30th, 2020
• Company
  Sintx Technologies, Inc.
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  New York

CONFIDENTIAL June 23, 2020

Placement Agent Agreement • June 24th, 2020 • Sintx Technologies, Inc. • Surgical & medical instruments & apparatus • New York

• Contract Type
  Placement Agent Agreement
• Filed
  June 24th, 2020
• Company
  Sintx Technologies, Inc.
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  New York

Adamis Pharmaceuticals Corporation 8-K

Placement Agent Agreement • February 21st, 2020 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York

• Contract Type
  Placement Agent Agreement
• Filed
  February 21st, 2020
• Company
  Adamis Pharmaceuticals Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This letter (the “Agreement”) constitutes the agreement between Adamis Pharmaceuticals Corporation (the “Company”) and Maxim Group, LLC (“Maxim” or the “Lead Manager”), that Maxim shall serve as the exclusive lead placement agent for the Company, on a “reasonable best efforts” basis ( a “Placement”), in connection with the proposed offerings of shares (the “Shares”) or the “Securities”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) and warrants to purchase shares of Common Stock (the “Warrants” and, together with the Shares, the “Securities”). The terms of such Placement and the Securities shall be mutually agreed upon by the Company and the Lead Manager and, if a Direct Placement, the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein grants Maxim the power or authority to bind the Company or any Purchaser or creates an obligation for the Company to issue any Securities or complete the Placement. This Agreement and